Showing 1–7 of 7 results
-
Amendments and Corrections |
Erratum: Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- Georgia Hatzivassiliou
- , Jacob R. Haling
- , Huifen Chen
- , Kyung Song
- , Steve Price
- , Robert Heald
- , Joanne F. M. Hewitt
- , Mark Zak
- , Ariana Peck
- , Christine Orr
- , Mark Merchant
- , Klaus P. Hoeflich
- , Jocelyn Chan
- , Shiuh-Ming Luoh
- , Daniel J. Anderson
- , Mary J. C. Ludlam
- , Christian Wiesmann
- , Mark Ultsch
- , Lori S. Friedman
- , Shiva Malek
- & Marcia Belvin
-
Amendments and Corrections |
Erratum: Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Ingrid E. Wertz
- , Saritha Kusam
- , Cynthia Lam
- , Toru Okamoto
- , Wendy Sandoval
- , Daniel J. Anderson
- , Elizabeth Helgason
- , James A. Ernst
- , Mike Eby
- , Jinfeng Liu
- , Lisa D. Belmont
- , Joshua S. Kaminker
- , Karen M. O’Rourke
- , Kanan Pujara
- , Pawan Bir Kohli
- , Adam R. Johnson
- , Mark L. Chiu
- , Jennie R. Lill
- , Peter K. Jackson
- , Wayne J. Fairbrother
- , Somasekar Seshagiri
- , Mary J. C. Ludlam
- , Kevin G. Leong
- , Erin C. Dueber
- , Heather Maecker
- , David C. S. Huang
- & Vishva M. Dixit
-
Research |
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- Georgia Hatzivassiliou
- , Jacob R. Haling
- , Huifen Chen
- , Kyung Song
- , Steve Price
- , Robert Heald
- , Joanne F. M. Hewitt
- , Mark Zak
- , Ariana Peck
- , Christine Orr
- , Mark Merchant
- , Klaus P. Hoeflich
- , Jocelyn Chan
- , Shiuh-Ming Luoh
- , Daniel J. Anderson
- , Mary J. C. Ludlam
- , Christian Wiesmann
- , Mark Ultsch
- , Lori S. Friedman
- , Shiva Malek
- & Marcia Belvin
-
Research |
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Ingrid E. Wertz
- , Saritha Kusam
- , Cynthia Lam
- , Toru Okamoto
- , Wendy Sandoval
- , Daniel J. Anderson
- , Elizabeth Helgason
- , James A. Ernst
- , Mike Eby
- , Jinfeng Liu
- , Lisa D. Belmont
- , Joshua S. Kaminker
- , Karen M. O’Rourke
- , Kanan Pujara
- , Pawan Bir Kohli
- , Adam R. Johnson
- , Mark L. Chiu
- , Jennie R. Lill
- , Peter K. Jackson
- , Wayne J. Fairbrother
- , Somasekar Seshagiri
- , Mary J. C. Ludlam
- , Kevin G. Leong
- , Erin C. Dueber
- , Heather Maecker
- , David C. S. Huang
- & Vishva M. Dixit
-
Research |
-
Research |
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- Paola Magnaghi
- , Roberto D'Alessio
- , Barbara Valsasina
- , Nilla Avanzi
- , Simona Rizzi
- , Daniela Asa
- , Fabio Gasparri
- , Liviana Cozzi
- , Ulisse Cucchi
- , Christian Orrenius
- , Paolo Polucci
- , Dario Ballinari
- , Claudia Perrera
- , Antonella Leone
- , Giovanni Cervi
- , Elena Casale
- , Yang Xiao
- , Chihunt Wong
- , Daniel J Anderson
- , Arturo Galvani
- , Daniele Donati
- , Tom O'Brien
- , Peter K Jackson
- & Antonella Isacchi
-
Research |
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- Georgia Hatzivassiliou
- , Kyung Song
- , Ivana Yen
- , Barbara J. Brandhuber
- , Daniel J. Anderson
- , Ryan Alvarado
- , Mary J. C. Ludlam
- , David Stokoe
- , Susan L. Gloor
- , Guy Vigers
- , Tony Morales
- , Ignacio Aliagas
- , Bonnie Liu
- , Steve Sideris
- , Klaus P. Hoeflich
- , Bijay S. Jaiswal
- , Somasekar Seshagiri
- , Hartmut Koeppen
- , Marcia Belvin
- , Lori S. Friedman
- & Shiva Malek
